Synthesis of some 3-(Arylalkylthio)-4-alkyl/aryl-5-(4-aminophenyl)-4H-1,2, 4-triazole derivatives and their anticonvulsant activity

Farmaco

Volumn 59, Issue 11, 2004, Pages 893-901

  Küçükgüzel, Ilkay ^a   Guniz Kucukguzel S ^a   Rollas, Sevim ^a   Ötük Saniş, Gülten ^b   Özdemir, Osman ^b   Bayrak, Ibrahim ^c   Altuǧ, Tuncay ^c   Stables, James P ^d  

^a MARMARA UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

1,2,4 Triazoles; Anticonvulsant activity; Maximal electroshock; Neurotoxicity; Pentylenetetrazole

Indexed keywords

1,2,4 TRIAZOLE DERIVATIVE; PENTETRAZOLE; RIFAMPICIN;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SCREENING; DRUG SYNTHESIS; ELECTRIC SHOCK; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTICONVULSANTS; ANTIFUNGAL AGENTS; DRUG EVALUATION, PRECLINICAL; ELECTROSHOCK; MALE; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; PENTYLENETETRAZOLE; RATS; ROTAROD PERFORMANCE TEST; SURVIVAL RATE; TRIAZOLES;

EID: 8444249712     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2004.07.005     Document Type: Article

References (31)

1. C Receptors Current Topics in Medicinal Chemistry 2 2002 903 913
2. Kehne J.H., Kane J.M., Chaney S.F., Hurst G., McCloskey T.C., Petty M.A., Senyah Y., Wolf H.H., Zobrist R., and White H.S. Preclinical characterization of MDL 27,192:as a potential broad spectrum anticonvulsant agent with neuroprotective properties Epilepsy Res. 27 1997 41 54
3. Kane J.M., Baron B.M., Dudley M.W., Sorensen S.M., Staeger M.A., and Miller F.P. 2,4-Dihydro-3H-1,2,4-triazol-3-ones as anticonvulsant agents J. Med. Chem. 33 1990 2772 2777
4. Ashton D., Fransen J., Heeres J., Clincke G.H., and Janssen P.A. In vivo studies on the mechanism of action of the broad spectrum anticonvulsant loreclezole Epilepsy Res. 11 1992 27 36
5. Kadaba P.K., Stevensen P.J., Nnane I.P., and Damani L.A. Triazolines-XXVII. delta2-1,2,3-triazoline anticonvulsants: novel 'built-in' heterocyclic prodrugs with a unique 'dual action' mechanism for impairing excitatory amino acid l-glutamate neurotransmission Bioorg. Med. Chem. 4 1996 165 178
6. Chimirri A., Gitto R., Quartarone S., Orlando V., De Sarro A., and De Sarro G.B. Synthesis and pharmacological propeties of new 3-ethoxycarbonyl-11H- [1,2,4]triazolo[4,5-c][2,3]benzodiazepines Farmaco 57 2002 759 763
7. Southam E., Stratton S.C., Sargent R.S., Brackenborough K.T., Duffy C., Hagan R.M., Pratt G.D., Jones S.A., and Morgan P.F. Broad spectrum anticonvulsant activity of BW534U87: possible role of an adenosine-dependent mechanism Pharmacol. Biochem. Behav. 74 2002 111 118
8. Akbarzadeh T., Tabatabai S.A., Khoshnoud M.J., Shafaghi B., and Shafiee A. Design and Synthesis of 4H-3-(2-Penoxy)phenyl-1,2,4-triazole Derivatives as Benzodiazepine Receptor Agonists Bioorg. Med. Chem. 11 2003 769 773
9. Kadaba P.K. Rational drug design and the discovery of the delta2-1,2,3-triazolines, a unique class of anticonvulsant and antiischemic agents Curr. Med. Chem. 10 2003 2081 2108
10. Rollas S., Kalyoncuoglu N., Sur-Altiner D., and Yegenoglu Y. 5-(4-Aminophenyl)-4-substituted-2,4-dihydro-3H-1,2,4-triazole-3-thiones: Synthesis and antibacterial and antifungal activities Pharmazie 48 1993 308 309
11. Kü̧ükgüzel I., Kü̧ükgüzel S.G., Rollas S., and Kiraz M. Some 3-thioxo/alkylthio-1,2,4-triazoles with a substituted thiourea moiety as possible antimycobacterials Bioorg. Med. Chem. Lett. 11 2001 1703 1707
12. Kalyoncuoglu N., Rollas S., Sür-Altiner D., and Yegenoglu Y. 1-[p-(Benzoylamino)benzoyl]-4-substituted thiosemicarbazides: Synthesis and antibacterial and antifungal activities Pharmazie 47 1992 796 797
13. Durgun B.B., and Rollas S. Synthesis and characterization of some arylhydrazones of p-(benzoylamino)benzoic acid hydrazide J. Pharm. Univ. Mar. 7 1991 107 111
14. Holla B.S., Shivananda M.K., Shenoy S., and Antony G. Studies on arylfuran derivatives--Part VIII. Synthesis, characterization and antibacterial activities of some 1-aminomethyl-3-substituted-4-[5-(4-nitrophenyl-2- furfurylidene)] amino-1,2,4-triazole-5-thiones Boll. Chim. Farmaceutico 137 1998 233 238
15. Rollas S. Reductive cleavage of azo compounds with hydrazine hydrate and some new 1,2,4-triazole derivatives II M.U. J. Sci. Technol. 3 1986 195 200 [ref.: CA 107, 58943d (1987)]
16. Kü̧ükgüzel S.G., Rollas S., Erdeniz H., and Kiraz M. Synthesis, characterization and antimicrobial evaluation of ethyl 2-arylhydrazono-3-oxobutyrates Eur. J. Med. Chem. 34 1999 153 160
17. Kü̧ükgüzel I., Rollas S., and Ülgen M. Synthesis and characteriaztions of some thiourea derivatives from 1,2,4-triazoline-3-thiones J. Pharm. Univ. Mar. 10 1994 17 25
18. Kömürcü S.G., Rollas S., Ülgen M., Gorrod J.W., and Çevikbas A. Evaluation of some arylhydrazones of p-aminobenzoic acid hydrazide as antimicrobial agents and their in vitro hepatic microsomal metabolism Boll. Chim. Farmaceutico 134 1995 375 379
19. Kü̧ükgüzel S.G., Rollas S., Kü̧ü kgüzel I., and Kiraz M. Synthesis and antimycobacterial activity of some coupling products from 4-aminobenzoic acid hydrazones Eur. J. Med. Chem. 34 1999 1093 1100
20. Stables J., and Kupferberg H.J. The NIH anticonvulsant drug development (ADD) program: preclinical anticonvulsant screening project Avanzini G. Regesta G. Tanganelli P. Avoli M. Molecular and Cellular Targets for Anti-epileptic Drugs 1997 191 198 (Chapter 16)
21. Dimmock J.R., Puthucode R.N., Smith J.M., Hetherington M., Quail J.W., Pugazhenthi U., Lechler T., and Stables J.P. (Aryloxy)aryl semicarbazones and related compounds: a novel class of anticonvulsant agents possessing high activity in the maximal electroshock screen J. Med. Chem. 39 1996 3984 3997
22. Porter R.J., Cereghino J.J., Gladding G.D., Hessie B.J., Kupferberg H.J., Scoville B., and White B.G. Antiepileptic drug development program Cleveland Clin. Quart. 51 1984 293 305
23. Flaherty P.T., Greenwood T.D., Manheim A.L., and Wolfe J.F. Synthesis and evaluation of N-(phenylacetyl)trifluoromethanesulfonamides as anticonvulsant agents J. Med. Chem. 39 1996 1509 1513
24. Unverferth K., Engel J., Höfgen N., Rostock A., Günther R., Lankau H.J., Menzer M., Rolfs A., Liebscher J., Müller B., and Hofmann H.J. Synthesis, anticonvulsant activity, and structure-;activity relationships of sodium channel blocking 3-aminopyrroles J. Med. Chem. 41 1998 63 73
25. Pandeya S.N., Yogeeswari P., and Stables J.P. Synthesis and anticonvulsant activity of 4-bromophenyl substituted aryl semicarbazones Eur. J. Med. Chem. 35 2000 879 886
26. Pandeya S.N., Raja A.S., and Stables J.P. Synthesis of isatin semicarbazones as novel anticonvulsants--role of hydrogen bonding J. Pharm. Pharmaceut. Sci. 5 2002 266 271
27. Barry A.L., and Thornsberry C. Susceptibility tests: Diffusion test procedures Lennette E.H. Balows A. Hausler W.J. Shadomy H.J. Manual of Clinical Microbiology 1986 ASM Washington DC 978 987
28. Jones R.N., Barry A.L., Gavan T.L., and Washington J.A. II Susceptibility tests: Microdilution and Macrodilution broth procedures Lennette E.H. Balows A. Hausler W.J. Shadomy H.J. Manual of Clinical Microbiology 1986 ASM Washington DC 972 977
29. Collins L., and Franzblau S.G. Microplate alamar blue assay versus BACTEC 460:system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium Antimicrob. Agents Chemother. 41 1997 1004 1009
30. Singh S.P., Pandey B.R., Kumar S., and Parmar S.S. Anticonvulsant activity and inhibition of respiration in rat brain homogenates by substituted trimethoxybenzamides J. Pharm. Sci. 67 1978 1682 1684
31. Srivastava V.K., Pandey B.R., Gupta R.C., and Kishor K. New CNS-active 3-methyl-4-substituted methyl-delta 2-isoxazolin-5-ones Pharmazie 34 1979 638 639